Esthesloneuroblastoma: Results and outcomes of a single institution's experience

Skull Base

Volumn 19, Issue 2, 2009, Pages 133-140

  Ward, P Daniel ^a,b   Heth, Jason A ^b   Thompson, B Gregory ^b   Marentette, Lawrence J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Esthesloneuroblastoma; Olefactory neuroblastoma; Skull base tumor; Subcranial

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE FREE SURVIVAL; ESTHESIONEUROBLASTOMA; FEMALE; FOLLOW UP; HUMAN; KARNOFSKY PERFORMANCE STATUS; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKULL SURGERY; SURVIVAL TIME; TERTIARY HEALTH CARE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR RECURRENCE;

EID: 63449091997     PISSN: 15315010     EISSN: 15320065     Source Type: Journal    
DOI: 10.1055/s-0028-1096195     Document Type: Article

References (33)

1. Berger L, Luc G, Richard D. The olfactory esthesioneuroepithelioma. Bull Assoc Fr Etud Cancer 1924;13;410-421
2. Broich G, Pagliari A, Ottaviani F. Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res 1997;17:2683-2706
3. Hyams VJ, Batsakis JG, Michaels L. Tumors of the upper respiratory tract and ear, Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology; 1988
4. Taxy JB, Bharani NK, Mills SE, Frierson HF Jr, et al. The spectrum of olfactory neural tumors. A light-microscopic immunohistochemical and ultrastructural analysis. Am J Surg Pathol 1986;10:687-695
5. Loy AH, Reibel JF, Thomas CY, et al. Estliesioneuroblastoma: continued follow-up of a single institution's experience. Arch Otolaryngol Head Neck Surg 2006;132: 134-138
6. Woertgen C, Rothoerl RE), Hosemann W, et al. Quality of life following surgery for malignancies of the anterior skull base. Skull Base 2007;17:119-123
7. Raveh J, Vuillemin T, Sutter F, Subcranial management of 395 combined frontobasal-midface fractures. Arch Otolaryngol Head Neck Surg 1988;114:1114-1122
8. Briant TD, Zorn M, Tucker W, Wax MK. The craniofacial approach to anterior skull base tumors. J Otolaryngol 1993;22:190-194
9. Roux FX, Pages JC, Nataf F, et al. Malignant ethmoidsphenoidal tumors. 130 cases. Retrospective study [in French]. Neurochirurgie 1997;43:100-110
10. Vanaclocha V, Saiz-Sapena N. Surgical treatment of anterior skull base tumours. Acta Neurochir (Wien) 1997; 139:857-868
11. Delfini R, Iannetti G, Belli E, et al. Cranio-facial approaches for tumours involving the anterior half of the skull base. Acta Neurochir (Wien) 1993;124:53-60
12. Pinsolle J, San-Galli F, Siberchicot F, et al. Modified approach for ethmoid and anterior skull base surgery. Arch Otolaryngol Head Neck Surg 1991;117:779-782
13. Jung TM, TerKonda RP, Haines SJ, et al. Outcome analysis of the transglabellar/subcranial approach for lesions of the anterior cranial fossa: a comparison with the classic craniotomy approach. Otolaryngol Head Neck Surg 1997;116(6 Pt l):642-646
14. Kellman KM, Marentette L, The transglabellar/subcranial approach to the anterior skull base: a review of 72 cases. Arch Otolaryngol Head Neck Surg 2001;127:687-690
15. Raveh J, Laedrach K, Speiser M, et al. The subcranial approach for fronto-orbital and anteroposterior skull-base tumors. Arch Otolaryngol Head Neck Surg 1993;119: 385-393
16. Zappia JJ, Carroll WR, Wolf GT, et al. Olfactory neuroblastoma: the results of modern treatment approaches at the University of Michigan, Head Neck 1993;15:190-196
17. Elkon D, Hightower SI, Lim ML, et al. Esthesioneuroblastoma. Cancer 1979;44:1087-1094
18. Morita A, Ebersold MJ, Olsen KD, et al. Esthesioneuroblastoma: prognosis and management. Neurosurgery 1993;32:706-714; discussion 714-715
19. Dulguerov P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 1992;102: 843-849
20. Resto VA, Eisele DW, Forastiere A, et al. Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck 2000;22:550-558
21. Diaz EM Jr, Johnigan RH 3rd, Pero C, et al. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck 2005;27:138-149
22. Jethanamest D, Morris LG, Sikora AG, Kutler DI. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg 2007;133:276-280
23. Ferlito A, Rinaldo A, Rhys-Evans PH. Contemporary clinical commentary: esthesioneuroblastoma: an update on management of the neck, Laryngoscope 2003;113;1935-1938
24. Dulguerov P,Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2001; 2:683-90
25. Simon JH, Zhen W, McCulloch TM, et al. Esthesioneuroblastoma; the University of Iowa experience 1978-1998. Laryngoscope 2001;111:488-493
26. Argiris A, Dutra J, Tseke P, Haines K. Esthesioneuroblastoma: the Northwestern University experience. Laryngoscope 2003;113:155-160
27. Chao KS, Kaplan C, Simpson JR, et al. Esthesioneuroblastoma: the impact of treatment modality. Head Neck 2001;23:749-757
28. Ahmad K, Fayos JV. Role of radiation therapy in the treatment of olfactory neuroblastoma. Int J Radiat Oncol Biol Phys 1980;6:349-352
29. Foote RL, Morita A, Ebersold MJ, et al. Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 1993;27:835-842
30. O'Connor TA, McLean P, Juillard GJ, Parker RG, Olfactory neuroblastoma. Cancer 1989;63:2426-2428
31. Polin RS, Sheehan JP, Chenelle AG, et al. The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma; the University' of Virginia experience. Neurosurgery' 1998;42:1029-1037
32. McElroy EA Jr, Buckner JC, Lewis JE, Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. Neurosurgery 1998;42:1023-1027; discussion 1027-1028
33. Spaulding CA, Kranyak MS, Constable WC, Stewart FM. Esthesioneuroblastoma: a comparison of two treatment eras. Int J Radiat Oncol Biol Phys 1988;15:581-590